IL113263A0 - Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases - Google Patents

Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases

Info

Publication number
IL113263A0
IL113263A0 IL11326395A IL11326395A IL113263A0 IL 113263 A0 IL113263 A0 IL 113263A0 IL 11326395 A IL11326395 A IL 11326395A IL 11326395 A IL11326395 A IL 11326395A IL 113263 A0 IL113263 A0 IL 113263A0
Authority
IL
Israel
Prior art keywords
treatment
pharmaceutical compositions
gastrointestinal diseases
pyridine compounds
imidazo pyridine
Prior art date
Application number
IL11326395A
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL113263A0 publication Critical patent/IL113263A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
IL11326395A 1994-04-11 1995-04-05 Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases IL113263A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9401197A SE9401197D0 (en) 1994-04-11 1994-04-11 Active compounds

Publications (1)

Publication Number Publication Date
IL113263A0 true IL113263A0 (en) 1995-10-31

Family

ID=20393591

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11326395A IL113263A0 (en) 1994-04-11 1995-04-05 Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases

Country Status (6)

Country Link
AU (1) AU2270695A (en)
IL (1) IL113263A0 (en)
IS (1) IS4274A (en)
SE (1) SE9401197D0 (en)
WO (1) WO1995027714A1 (en)
ZA (1) ZA952860B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101255164A (en) * 1997-05-28 2008-09-03 奥坦纳医药公司 Residual current circuit breaker fused dihydropyrans and uses thereof
TR200100805T2 (en) * 1998-09-23 2001-08-21 Byk Gulden Lomberg Chemische Fabr�K Gmbh they Tetrahidropiridoet
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
ATE332302T1 (en) 2000-03-29 2006-07-15 Altana Pharma Ag ALKYLATED IMIDAZOPYRIDINE DERIVATIVES
DE60127131T2 (en) * 2000-03-29 2007-11-22 Nycomed Gmbh TRICYCLIC IMIDAZOPYRIDINE
NZ520836A (en) * 2000-03-29 2005-01-28 Altana Pharma Ag Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders
MXPA02009551A (en) * 2000-03-29 2004-05-14 Altana Pharma Ag Prodrugs of imidazopyridine derivatives.
AU2002210563B2 (en) 2000-10-25 2007-03-01 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (en) 2000-12-07 2007-09-25 Алтана Фарма Аг Pharmaceutical preparation comprising an pde inhibitor dispersed on a matrix
CN1656096A (en) * 2001-08-03 2005-08-17 奥坦纳医药公司 Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
EP1417208A1 (en) * 2001-08-03 2004-05-12 ALTANA Pharma AG Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
SI1419163T1 (en) * 2001-08-10 2005-12-31 Altana Pharma Ag Tricyclic imidazopyridines
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
US7211590B2 (en) 2002-08-01 2007-05-01 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
AU2004226180A1 (en) 2003-04-04 2004-10-14 Altana Pharma Ag Cyclic benzimidazoles
WO2005058894A1 (en) * 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
JP2007529472A (en) * 2004-03-17 2007-10-25 アルタナ　ファルマ　アクチエンゲゼルシャフト Tricyclic imidazopyridine
WO2007141253A1 (en) * 2006-06-07 2007-12-13 Nycomed Gmbh Process for the production of intermediates for the preparation of tricyclic imidazopyridines
US20080103169A1 (en) 2006-10-27 2008-05-01 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
AU2009215514B9 (en) 2008-02-20 2014-01-30 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines

Also Published As

Publication number Publication date
AU2270695A (en) 1995-10-30
WO1995027714A1 (en) 1995-10-19
IS4274A (en) 1995-10-12
ZA952860B (en) 1996-01-12
SE9401197D0 (en) 1994-04-11

Similar Documents

Publication Publication Date Title
IL113263A0 (en) Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
IL117957A0 (en) Pharmaceutical compositions for the treatment of impotence
HUP0003851A3 (en) Pharmaceutical composition for the treatment or prevention of glomerulopathy
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
EP0777474A4 (en) Methods for the treatment of inflammatory joint disease
IL124768A0 (en) Novel pyridine compounds processes for their preparation and their use as pharmaceutical agents
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
HK1036274A1 (en) Imidazo (1,2-a) pyridine derivatives for the treatment of gastrointestinal diseases
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
EP0577023A3 (en) Angiotensin-ii receptor-antagonists for the treatment of arrhythmices
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
HUP9900309A3 (en) Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases
HUP9901247A3 (en) Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency
EP0981357A4 (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
HUP9903688A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating autism
IL106751A0 (en) Pharmaceutical compositions for the treatment of reversible obstructive airways diseases
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
IL120005A0 (en) Pharmaceutical compositions for the treatment of the eye
EP0755262A4 (en) Composition for the treatment of lung disease
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
EP0979234A4 (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
IL112223A0 (en) Pharmaceutical compositions for the treatment of neurological inflammatory conditions
HUP9801985A3 (en) Use of cystine derivatives for the preparation of pharmaceutical compositions useful for the treatment of restenosis